ADMIRAL

(redirected from Admiral's)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.
Related to Admiral's: Admiral's Men
Abciximab before Direct Angioplasty & Stenting in Myocardial Infarction Regarding Acute & Long-Term Follow-Up. A trial assessing clinical benefit of abciximab + primary stenting for acute MI
Primary endpoint Composite—death, reinfarction, urgent revascularization of target vessel at 30 days
Conclusion Early abciximab in acute MI improves coronary patency before stenting, stenting success, coronary patency at 6 months, recovery of left ventricular function, outcomes

ADMIRAL

Cardiology A clinical trial–Abciximab before Direct Angioplasty & stenting in Myocardial Infarction Regarding Acute and Long-term followup. See Abciximab, Angioplasty, Myocardial infarction, Stenting.
Mentioned in ?
References in periodicals archive ?
Having fun and engaging employees, core elements of Admiral's Ministry of Health programme
As already one of the most efficient providers of car insurance in the UK, this investment will strengthen Admiral's position in a competitive market.
We are making this gift in recognition of the hard work and team spirit that has underpinned Admiral's success as we've grown from a start-up with value of PS0 to a FTSE 100 company with a value of PS5bn today.
Research shows that 89% of Admiral's staff are proud of its sponsorship with the WRU.
Admiral's ENVIROTERRA(tm) product line is the first high performance completely biodegradable non-acid and non-corrosive, all-purpose industrial liquid cleaners.
Admiral's products ENVIROTERRA and TEMPEST are the first completely biodegradable non-acid and non-corrosive, all-purpose industrial liquid cleaners which are Agriculture Canada approved for use in food and beverage processing facilities.
Bayer, Chairman and CEO, indicated sales growth was a result of business acquisitions made during the previous fiscal year combined with increased sales to existing clients of Admiral's environmentally-friendly products.
Edward A Bayer, Chairman and CEO of Admiral, stated that growth was due to three primary factors: increased sales of existing products to current and new clients; major new multi-year contracts; and the acceptance of Admiral's new products launched in fiscal 1997.
This manufacturing now moves to Admiral's Toronto facility, contributing greatly to the efficiencies within our plant.
Bayer, Chairman and CEO of Admiral: "This acquisition dramatically broadens Admiral's scope, taking us into a proven consumer product category.
Sanchez will turn over CEO duties to Admiral Zlatoper and will look to the Admiral's much-admired management abilities and international market knowledge to help Sanchez implement a global expansion plan and work to meet market demand for its PROFILE(R)/Anyware software.
This Report covered Admiral's first year as a public company pursuant to its IPO in April of 1996.